HTGC

Hercules Capital, Inc. 2015 Form 10-K Summary

Business Context and Reporting Period

This Annual Report on Form 10-K covers the fiscal year ended December 31, 2015, for Hercules Capital, Inc. (formerly Hercules Technology Growth Capital, Inc.). The Company is an internally managed, non-diversified closed-end investment company regulated as a Business Development Company (BDC) under the Investment Company Act of 1940 and taxed as a Regulated Investment Company (RIC). Its primary strategy is providing senior secured venture growth loans, structured debt with warrants, and equity investments to high-growth, venture capital-backed companies in technology, life sciences, and sustainable/renewable technology sectors.

Key Financial Metrics

Material Changes vs. Prior Period

• Portfolio Growth: The investment portfolio grew by approximately 17.6% to $1.2 billion, driven by new fundings of $694.1 million in debt and $18.6 million in equity. However, this was partially offset by $503.6 million in principal repayments, including $388.5 million in early payoffs.
• Net Income Decline: Net increase in net assets from operations decreased by 39.7% to $42.9 million. This decline was primarily due to a significant increase in net unrealized depreciation ($35.7 million in 2015 vs. $20.7 million in 2014) and a decrease in net realized gains.
• Unrealized Depreciation Drivers: The $35.7 million unrealized loss was attributed to collateral-based impairments on ten portfolio companies ($20.4 million), depreciation on public equity holdings (notably Box, Inc.), and private warrant portfolio depreciation.
• Expense Increases: Total operating expenses rose 18.9% to $83.6 million, driven by a 63.2% increase in general and administrative expenses (due to recruiting and legal costs) and a 24.2% increase in employee compensation.
• Debt Structure: The Company redeemed $60.0 million of 2019 Notes and fully repaid the 2017 Asset-Backed Notes. It also utilized the Wells Facility, with $50.0 million outstanding at year-end.

Guidance, Outlook, Risks, and Unusual Items

• Dividend Policy: The Company maintains a variable dividend policy targeting 90-100% of taxable income. A quarterly dividend of $0.31 per share was declared in February 2016. The Company intends to distribute approximately $8.2 million of spillover earnings in 2016.
• Capital Resources: As of December 31, 2015, the Company had $195.2 million in available liquidity, including $95.2 million in cash and $100.0 million in available borrowing capacity under credit facilities. A $50.0 million stock repurchase plan was active with $45.4 million remaining.
• Key Risks:
  • Concentration Risk: 63.0% of the portfolio is concentrated in four industries: Drug Discovery (23.7%), Drug Delivery (13.7%), Sustainable/Renewable Tech (13.3%), and Software (12.3%).
  • Valuation Uncertainty: Approximately 90% of assets are Level 3 investments valued by the Board of Directors, creating inherent uncertainty in fair value determinations.
  • Leverage: The Company utilizes significant leverage (total leverage ratio of 219.4% including SBA debentures). A decline in asset values could trigger covenant breaches or force asset sales.
  • Prepayment Risk: High levels of early repayments ($388.5 million) in 2015 reduced effective yields and created reinvestment risk.
• Unusual Items: The Company recorded a $143,000 reduction in realized gains due to a warrant participation agreement with Citigroup. Additionally, $1.2 million in realized losses were recognized from the partial write-off of a debt investment on non-accrual.

Investor Verification Checklist

• Verify the specific portfolio companies contributing to the $20.4 million in collateral-based impairments and their current status.
• Confirm the valuation methodology and inputs used for the Level 3 assets, particularly the private warrants and debt investments in the sustainable technology sector.
• Review the terms of the Wells Facility and Union Bank Facility to understand the impact of the 50% advance rate on future lending capacity.
• Assess the impact of the $75.4 million in unfunded commitments on future cash flow requirements.
• Monitor the performance of the two largest portfolio holdings (Machine Zone, Inc. and Sungevity Development, LLC), which represent over 21% of net assets combined.
• Check the status of the $190.2 million in SBA-guaranteed debentures and compliance with SBA leverage regulations.